Migraine Attack Pain Phase Prediction Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorFundación de Investigación Biomédica - Hospital Universitario de La Princesa
About this trial
The study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La Princesa since 2013 together with the Complutense and Polytechnic University of Madrid. Their results have been reflected in various publications (Pagán J, et al. Sensors 2015; Gago-Veiga AB, et al. J Pain Res 2018) and have promoted the creation of several invention patents.
Eligibility criteria
Qualifiers
Age between 15 years and 69 years.
Diagnosed with migraine by a headache neurologist and according to the criteria proposed by ICHD-3.
History of migraine of at least 1 year of evolution.
Normal neurological examination.
Disqualifiers
Presence of another type of headache, with the exception of headache due to excessive use of analgesic medication.
Cognitive deficiency or any other pathology that may prevent or make it difficult for the patient to perform the study correctly.
Neurological focus in the examination.
Pregnancy or breastfeeding period.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
70 Participants
are grouped into 2 trial groupsSponsors and collaborators
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Lead sponsor
Hospital Vall d'Hebron
Collaborator
Hospital Donostia
Collaborator
Hospital Universitario Marqués de Valdecilla
Collaborator
Hospital Clínico Universitario Lozano Blesa
Collaborator
Hospital Universitario La Fe
Collaborator
Hospital Clínico Universitario de Valladolid
Collaborator
Source ClinicalTrials.gov